Form 4: Sera Prognostics Chief Data Officer Cancels Stock Options, Receives Restricted Stock Units

Paul Kearney, Chief Data Officer of Sera Prognostics, canceled stock options and received restricted stock units (RSUs) in exchange.

Summary

• On May 10, 2024, Paul Kearney, the Chief Data Officer of Sera Prognostics, canceled stock options for 44,646 shares of Class A Common Stock.
• In exchange, Mr. Kearney received 40,854 restricted stock units (RSUs) that vest immediately.
• The RSUs were granted at a price of $0 per share.
• Following the transaction, Mr. Kearney beneficially owns 195,687 shares of Class A Common Stock.
• The canceled stock options had an exercise price of $0.83 per share and were set to expire on August 20, 2024.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The exchange of options for RSUs is a fairly standard practice.

Positives

• The immediate vesting of RSUs may incentivize the Chief Data Officer to remain with the company.

Industry Context

Stock options and restricted stock units are common forms of executive compensation in the biotechnology industry, used to align management's interests with those of shareholders.

Comparison to Industry Standards

• The exchange of stock options for RSUs is a fairly common practice, often used to simplify equity compensation structures or to provide executives with more certain value.
• Many biotech companies use a mix of stock options and RSUs to incentivize their executives, with the specific mix depending on the company's stage of development and its overall compensation philosophy.
• Comparing Sera Prognostics' equity compensation practices to those of similar-sized biotech companies would provide a better understanding of whether these transactions are in line with industry norms.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if it is viewed as aligning management's interests with those of shareholders.

Key Dates